Recent research has identified a specific biological mechanism that may explain why females experience more severe ...
A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...
New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...
Alzheimer’s disease is the most common cause of dementia and most often affects individuals older than 60. Image: PSJ Design ...
Potentially more than 90% of Alzheimer's disease cases would not occur without the contribution of a single gene (APOE), ...
EMA approval decision for obicetrapib and obicetrapib/ezetimibe fixed dose combo expected in 2H26 ---- Phase 3 PREVAIL CVOT overall event rate ...
Amazon S3 on MSN
Track these warning signs in your mid-30s to fight Alzheimer’s
Track These Warning Signs in Your Mid-30s , To Fight Alzheimer’s. A recent study suggests that people in their 30s and 40s ...
Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP(TM) (Mercury ...
Funds to support ongoing Phase 1 trial of MNA-001 and validation of translational biomarkers for TREM2 function in Alzheimer's Work will inform Phase 2 trials assessing the potential of MNA-001 to ...
But cell and gene therapies (CGTs) are catching up. During Cell and Gene Therapy International Europe 2025, held in Berlin, ...
Find out more about how blood from older donors may speed Alzheimer’s progression and what this means for future therapies.
Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback